At the news
? NEUTRALIMPACT 3/10 CLUSTER filed Mar 2, 2026 at 19:00 ET
Seven executives at Quest Diagnostics executed tax withholding transactions, surrendering shares worth $1.06M, while three SVPs sold shares in the open market for a total of $326K. The sales are modest in size and likely part of pre-arranged trading plans, not a signal of distress.
- Three executives conducted open-market sales totaling $326K (0.0014% of $22.9B market cap).
- Seven insiders, including CEO, CFO, and other SVPs, surrendered shares to cover tax obligations, totaling $1.06M.
- All transactions occurred over a 2-day window, consistent with routine post-vesting share dispositions.
- No purchases or derivative exercises were reported.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access